MedWatch

Novo Nordisk bets on digital health: "We experience a great demand"

With the announcement of new products and partnerships, Novo Nordisk reveals bits of the plans for the its entry into the digital health market.

Foto: Ritzau Scanpix/Søren Bidstrup

Denmark's largest drug group, Novo Nordisk, has an eye for the digital health market and signed several partnership deals to bring new intelligent solutions to its customers.

Earlier this month, Novo Nordisk announced the upcoming launch of two intelligent durable insulin pens to be used with other manufacturers' blood glucose measurement devices and a smartphone. The aim is to help patients keep an electronic log of blood glucose levels and insulin consumption.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier